The Dawn of Targeted Therapy: How 2025 FDA Approvals are...

added blog Health

2025-12-18 11:03:31 -

The Dawn of Targeted Therapy: How 2025 FDA Approvals are Transforming the IgG4-RD Landscape

Immunoglobulin G4-related disease (IgG4-RD) has long been a challenge for clinicians due to its ability to mimic various malignancies and infections. Characterized by fibro-inflammatory lesions and the infiltration of IgG4-positive plasma cells, this systemic condition can damage the pancreas, kidneys, and salivary glands if left unmanaged. Historically, the medical community relied almost...

0 Comments 0 Shares 4K Views 0 Reviews